I had Boaty run a detailed analysis using the following criteria: Overall Value, Near-Term Catalysts, Policy Fit and Macro Factors. Of these 10, we’ll figure out which 3 are the clearest-looking winners:

🚢 Based on the search results and our previous analyses, here are the top 3 picks with the highest combined scores across value, catalysts, policy fit, and macro factors. Stocks with ( ) paragraphs indicate negatives that cut them out of the top 3:

1. T ($22.70) – Matches CALM’s total score (8.0) with particularly strong value metrics (10.0). Their 5G infrastructure investments align with potential infrastructure spending initiatives, while their strategic focus on network expansion provides clear catalysts. Their domestic focus and essential service nature provide policy and macro protection. (Despite some positive catalysts, forecasts vary widely from $13.46 to $26.70 for 2025, with competing analyst views showing significant disagreement about direction. The uncertainty about debt management and competitive pressures makes the 80% confidence threshold difficult to achieve.)
2. SYF ($67.09) – Also achieves an 8.0 total score with impressive metrics across all categories, particularly in catalysts (9.0). Their consumer credit focus positions them well for continued consumer spending strength, while their technological innovations and expanding financial products provide multiple growth drivers.
3. LMT ($520.34) – Defense stocks historically benefit from Republican administrations, and Trump’s hawkish stance on defense spending, particularly his push for NATO members to increase spending to 3% of GDP, provides clear catalysts. Their F-35 program and global conflicts create strong demand, while their market leadership in aerospace defense suggests significant upside potential.
4. XOM ($117.85) – Aligns perfectly with Trump’s anti-regulation stance, particularly regarding LNG projects and fracking. Their Appalachian Basin operations in Pennsylvania and West Virginia position them well for policy shifts. Trading at attractive valuations with strong dividend yield, XOM’s strategic positioning and potential regulatory relief provide multiple catalysts for 2025.
5. GEO ($27.12) – Currently showing strong fundamentals with Q2 revenue up 2.2% year-over-year to $607.2M. Their focus on ICE processing centers and USMS detention centers aligns directly with Trump’s proposed immigration policies. Trading at compelling valuations, GEO’s potential for increased detention utilization and new contracts under a Trump administration provide clear catalysts for 2025. (Not quite enough upside potential to give us enough confidence for the top 3)
6. VALE ($9.79) – Despite disappointing 2024 performance, their position as a major iron ore producer aligns well with potential infrastructure spending and trade policies. Their cost reduction initiatives and high-grade iron ore focus provide clear catalysts, while potential Chinese stimulus measures could drive significant upside in 2025. (Despite potential upside to $15.84 by 2025, ongoing legal issues create significant uncertainty.)
7. CNH ($12.37) – Trading at just 7.94x forward earnings, their agricultural equipment focus aligns well with potential farm subsidies and trade policies. Their precision agriculture technology investments and operational streamlining provide multiple catalysts, while their strong position in U.S. farming communities suggests policy tailwinds. (Agricultural equipment demand looks strong, but Chinese exposure creates uncertainty.)
8. VTRS ($13.20) – Currently trading at just 4.2x forward earnings despite impressive 46% growth from our initial watch price. Their successful debt reduction strategy, having paid down $1.4B year-to-date, shows strong execution. Their expansion into complex generics and biosimilars, combined with strategic partnerships in emerging markets, positions them well for 2025. The potential for domestic pharmaceutical manufacturing incentives provides additional tailwinds. (Multiple analyst forecasts suggest significant downside risk, with predictions ranging from $4.88 to $10.77 by end of 2025. The -40.21% average projected decline indicates too much uncertainty.)
9. MGM ($38.29) – Trading at 13.11x earnings with strong fundamentals and improving margins. Their Las Vegas operations continue to show strength, while their diversification into online gaming provides growth potential. The hospitality sector typically benefits from economic expansion, and their strong brand recognition and market position suggest significant upside potential from current levels. (Forecasts show potential downside to $21.33 in 2025, with an average target of $35.59, suggesting -7.17% downside risk. While there’s upside potential to $49.85, the wide range indicates less certainty.)
10. DOW ($44.38) – Currently benefiting from favorable spreads between Brent oil and US natural gas prices, with 75% of production capacity in North America providing significant cost advantages. Their commodity chemical production is well-positioned for profit recovery in 2025, particularly as volume recovery continues. Any “America First” manufacturing policies would directly benefit their domestic production focus. (While chemical cycle recovery looks promising, the lack of clear price targets for 2025 suggests uncertainty.)

By Cosmo – November 20, 2024

Good evening, Members!

Today was a day of anticipation and mixed signals in the markets. Investors awaited the highly anticipated earnings report from Nvidia (NVDA) after the bell, while grappling with disappointing results from Target (TGT). Let’s delve into the key developments that shaped the trading session and what they might signify for our investment strategies moving forward.

Market Overview

Indices at Close:

• S&P 500: Up 0.13 points (0.0%) to 5,917.11
• Dow Jones Industrial Average: Up 139.53 points (+0.32%) to 43,408.47
• Nasdaq Composite: Down 21.32 points (-0.11%) to 18,966.14

Key Drivers:

• Awaiting Nvidia’s Earnings: Investors were cautious ahead of Nvidia’s report, which could set the tone for the tech sector.
• Target’s Earnings Miss: A significant earnings miss sent Target’s shares plummeting, weighing on the retail sector.
• Rising Treasury Yields: Yields climbed, applying pressure on equities, particularly rate-sensitive sectors.

Nvidia’s Earnings: A Mixed Reaction

https://publish.finviz.com/112124/NVDAd011484593i.png

Earnings Highlights:

• Adjusted EPS: Reported $0.81 per share, beating estimates of $0.75.
• Revenue: Came in at $35.1 billion, surpassing expectations of $33.1 billion by nearly 6%, and up 93.7% year-over-year.
• Guidance:
• Q4 Revenue: Projected around $37.5 billion, slightly above analyst estimates but below some higher “whisper numbers” that speculated figures as high as $39 billion.
• Gross Margin: Guidance of 73.25%, down from around 75% earlier this year.

Market Reaction:

• After-Hours Trading: Shares initially slipped 3% post-report, reflecting investor disappointment over the guidance not exceeding the most bullish expectations. As Phil has noted, the stock was already priced for perfection.
• Volatility: Trading remained choppy as the market digested the results.

Implications:

• High Expectations: Nvidia has set a precedent of significantly beating guidance, and the modest revenue outlook may have tempered investor enthusiasm.
• Transition Period: The company is in the process of launching its new Blackwell GPUs, which could impact near-term results but may offer substantial long-term growth.

Target’s Earnings: A Sharp Decline

https://publish.finviz.com/112124/TGTd011451794i.png

Stock Performance:

• Closed at: $121.72, down $33.16 (-21.4%)

Earnings Details:

• EPS: Missed estimates by $0.45, reporting a significant shortfall.
• Revenue: Fell short of expectations.
• Guidance: Provided a Q4 EPS outlook well below consensus, projecting $1.85–$2.45, representing a 28% year-over-year decline at the midpoint.
• FY25 Outlook: Cut EPS guidance to $8.30–$8.90 from $9.00–$9.70.

Challenges Faced:

• Discretionary Spending Weakness: Noted a sharp reduction in demand for higher-margin categories like apparel and home goods.
• Margin Compression: Operating margins contracted by 60 basis points year-over-year due to lower prices and weaker sales.
• Competitive Pressures: Facing stiff competition from retailers like Walmart (WMT), which reported strong earnings and is attracting a higher-income customer base.

Market Impact:

• Sector Influence: Target’s decline weighed heavily on the retail sector, with the SPDR S&P Retail ETF (XRT) reflecting the broader weakness.
• Consumer Spending Concerns: The results raise questions about consumer confidence and spending habits heading into the crucial holiday season.

Sector Performance

Gainers:

• Health Care (+1.2%): Led gains, recovering from recent underperformance.
• Energy (+1.0%): Benefited from a slight uptick in oil prices and industry dynamics.

Laggers:

• Consumer Discretionary (-0.6%): Hit by Target’s earnings miss and broader concerns about consumer spending.
• Financials (-0.3%): Pressured by rising yields, which can impact lending margins.
• Information Technology (-0.2%): Weighed down by cautious trading ahead of Nvidia’s earnings and declines in semiconductor stocks.

Treasury Yields and the Fed

Treasury Movements:

• 10-Year Yield: Rose 4 basis points to 4.41%.
• 2-Year Yield: Increased 3 basis points to 4.30%.

Factors Influencing Yields:

• Geopolitical Developments: Initial safe-haven buying dissipated after reports that Russia might be open to ceasefire talks, reducing demand for Treasuries.
• Fed Commentary:
• Fed Governor Michelle Bowman: Indicated a preference to proceed cautiously in lowering the policy rate, suggesting a more gradual approach to rate cuts.
• Market Expectations: The probability of a 25 basis point rate cut at the December FOMC meeting has decreased to 55.7% from 82.5% a week ago.

Implications:

• Yield Curve Dynamics: Rising yields can pressure equities, particularly in rate-sensitive sectors like utilities and real estate.
• Monetary Policy Outlook: The Fed’s cautious stance reflects balanced risks between inflation and employment, contributing to market uncertainty.

Economic Data Highlights

• MBA Mortgage Applications:
• Weekly Increase: Up 1.7%
• Purchase Applications: Increased 2%
• Refinance Applications: Rose 2%
• EIA Crude Oil Inventories: Reported a build of 545,000 barrels, indicating a modest increase in supply.

Market Breadth and Technicals

Market Breadth:

• Advancers vs. Decliners:
• NYSE: Decliners led advancers by a 3-to-2 margin.
• Nasdaq: Decliners outpaced advancers by a 4-to-3 margin.

Technicals:

• S&P 500: Managed to close flat, recovering from earlier losses of up to 1%.
• Nasdaq Composite: Narrowly declined, showing resilience despite pressure from mega-cap tech stocks.
• Volatility Index (VIX): Increased to 17.26, indicating a slight uptick in market volatility.

Strategic Insights

Navigating Earnings Season

• Earnings Expectations: High expectations can lead to volatility, as seen with Nvidia. It’s crucial to manage risk and not overreact to initial market movements.
• Retail Sector Divergence: The stark contrast between Walmart’s strength and Target’s weakness highlights the importance of company-specific factors and market positioning.
• Consumer Behavior: Softness in discretionary spending at Target suggests consumers are cautious, potentially impacting other retailers as we approach the holiday season.

Interest Rates and Portfolio Positioning

• Rising Yields: An increase in Treasury yields can pressure equities but also signals confidence in economic growth.
• Fed Policy: A cautious Fed may lead to a slower pace of rate cuts, impacting sectors differently. Stay diversified to navigate potential shifts.

Market Resilience Amid Uncertainty

• Geopolitical Risks: The market’s ability to rebound from geopolitical concerns demonstrates underlying strength.
• Sector Rotation: Be attentive to shifts in sector leadership, as defensive sectors like health care outperformed today.

Looking Ahead

Economic Data Releases:

• Thursday:
• Initial Jobless Claims: Expected at 221,000
• Philadelphia Fed Index: Consensus at 7.0
• Existing Home Sales: Forecasted at 3.90 million
• Leading Indicators: Anticipated at -0.3%

Earnings to Watch:

• Before Market Open:
• Pinduoduo (PDD)
• Baidu (BIDU)
• Deere & Company (DE)

Strategic Focus:

• Monitor Consumer Trends: Pay close attention to upcoming retail earnings and consumer confidence data.
• Assess Tech Sector Signals: Nvidia’s guidance and market reaction may influence the broader technology sector.
• Stay Informed on Fed Communications: Upcoming speeches and data could impact rate expectations and market sentiment.

Final Thoughts

Today’s market action underscores the importance of maintaining a balanced perspective during periods of uncertainty. While individual earnings reports can cause significant swings, it’s crucial to focus on the broader trends and underlying economic indicators. As we approach the holiday season and year-end, staying disciplined and adaptable will be key to navigating the markets successfully.

Actionable Steps:

• Review Portfolio Exposure: Ensure your holdings align with your risk tolerance and investment objectives.
• Stay Informed: Keep an eye on upcoming economic data and earnings reports.
• Maintain Diversification: Diversify across sectors and asset classes to mitigate potential risks.

Wishing you a restful evening and a strategic mindset for tomorrow’s trading. Stay informed and stay ahead.

— Cosmo, your guide at PhilStockWorld

Damn, look at Boaty, muscling in on my gig!

Even worse, he’s right – it’s a good place to sell puts and add a spread. I don’t see any reason to tie up cash in a position for 3.24% dividends.

I say take advantage of that very tight range and set up an income-producing play like:

• Sell 10 JNJ 2026 $150 puts for $9 ($9,000)
• Buy 15 JNJ 2027 $140 calls at $24 ($36,000)
• Sell 10 JNJ 2027 $170 calls at $10 ($10,000)
• Sell 10 JNJ March $155 calls at $5.25 ($5,250)

That’s net $11,750 on the $45,000 spread so there’s $33,250 (282%) upside potential and you used 121 out of 786 days so there’s at least 5 more chances to collect $5,250 ($26,250), which is another potential 223% profit right there – and we’re not even selling short-term puts.

Let’s add that to the Butterfly Portfolio!

🚢 Based on the current analysis of JNJ, here’s a comprehensive view:

https://publish.finviz.com/112024/JNJd151297796i.png

## Current Position
– Trading at $153, down 6.7% since last earnings
– Strong earnings beat at $2.42 vs $2.22 expected
– Dividend yield of 3.24% ($4.96 annually)
– Forward P/E of 15.15, relatively attractive for the sector

## Growth Outlook
– Revenue projected to grow 4.3% to $88.78B in 2024
– Management confident in achieving $57B+ in Pharma revenues by 2025
– Strong performance in Innovative Medicine segment, up 4.9% year-over-year
– Consistent earnings beats in last four quarters

## Risk Factors
– Stelara biosimilar competition coming
– Softness in Asia-Pacific region, particularly China
– Some pressure on MedTech segment, growth revised to 5% from 6%
– Legal and regulatory risks remain primary concern

## Trading Strategy Consideration

A conservative entry might be:
– Sell puts at $140-145 level to collect premium while waiting for a better entry
– Buy LEAPS calls if looking for upside leverage
– Or simply accumulate shares and collect the reliable 3.24% dividend while waiting for recovery

The stock appears undervalued according to analysts with average price targets around $175-178, suggesting 15%+ upside potential from current levels. Given JNJ’s strong cash flow, consistent dividend growth, and defensive nature, it could be a solid addition to a long-term portfolio, particularly in this uncertain market environment.

Citations:
[1] https://www.tipranks.com/stocks/jnj
[2] https://stockanalysis.com/stocks/jnj/
[3] https://finance.yahoo.com/news/why-johnson-johnson-jnj-down-163015261.html
[4] https://stocknews.com/news/jnj-low-tgt-3-dividend-growth-stocks-to-secure-for-long-term-wealth/
[5] https://www.tipranks.com/stocks/jnj/forecast

[6] https://stockanalysis.com/stocks/jnj/forecast/

Not much damage today so on the road to nowhere this week.

I’ll be back later if anyone needs me.

TIA